Conatus Discusses Its Liver Disease Therapy Emricasan at Two New York Events
Liver cirrhosis, News, Non-alcoholic fatty liver disease, Non-alcoholic steatohepatitis
Conatus Pharmaceuticals updated participants at two New York medical conferences this month on its efforts to develop emricasan, which has been shown to ... Read more